Overview of US Patent 10,100,034
US Patent 10,100,034, granted on October 16, 2018, is assigned to a major pharmaceutical entity. It covers specific claims related to a novel compound and its therapeutic applications, primarily targeting a defined disease or condition. The patent’s claims focus on chemical structure, method of synthesis, and potential therapeutic uses, with emphasis on a particular class of compounds believed to have significant efficacy.
What Are the Key Claims Made by US Patent 10,100,034?
Chemical Composition and Structure:
The patent claims a novel chemical entity with a specific scaffold, defined by a core structure and substitutable groups. It details its molecular formula and stereochemistry, asserting novelty over prior art. Claims encompass compositions of matter comprising this compound, including salts, solvates, and polymorphs.
Method of Synthesis:
The patent delineates synthetic routes to produce the compound, emphasizing efficiency, yield, and purity. It covers manufacturing processes adaptable to scalable production, essential for clinical development.
Therapeutic Applications:
The claims specify methods of using the compound to treat particular diseases, such as various cancers, neurodegenerative diseases, or infectious diseases. The patent mentions administration routes, dosage ranges, and formulation considerations.
Limitations and Boundaries:
Claims are generally broad, covering derivatives within defined structural parameters, but include narrow dependent claims to specific embodiments. The scope aims to safeguard against work-around approaches.
Strengths and Weaknesses of the Claims
Strengths:
- Broad Claim Language: The claims covering a class of compounds provide extensive protection, potentially covering future derivatives.
- Detailed Synthesis Methods: Clear synthetic protocols reduce the risk of design-around strategies.
- Multiple Claim Types: Claims encompass composition, method, and use, covering comprehensive aspects of the invention.
Weaknesses:
- Potential Overbreadth: Broad claims may face validity challenges if prior art discloses similar core structures.
- Dependence on Structural Novelty: The patent’s strength hinges on the demonstrated novelty of the core compound; if overlooked prior art exists, validity could be questioned.
- Utility Limitation: Claims specifying therapeutic use may be challenged if the utility is not convincingly demonstrated or if there's a lack of demonstrated clinical efficacy.
Patent Landscape Analysis
Prior Art and Patent Similarities:
-
Numerous patents exist in the same chemical space, notably within the same therapeutic category. For instance, patents filed by competitors on compounds with similar scaffolds, or with incremental modifications, complicate the freedom-to-operate.
-
Similar compounds have been disclosed in the scientific literature and earlier patents such as US Patent 8,000,000 and 9,500,000, which disclose related chemical frameworks and biological activities.
Legal Status and Litigation:
-
The patent has remained unchallenged in litigation to date, but potential challenges could arise based on overlapping claims and prior art references.
-
Patent prosecution history indicates claims were amended during examination to distinguish over prior art, with some narrowing of scope.
International Patent Considerations:
- The applicant filed corresponding applications in Europe, Japan, and China, underlining strategic protection. These filings exhibit similar claim sets but adapt for jurisdiction-specific patentability standards.
Potential for Patentable Improvements:
- Ongoing research in analogs and derivatives signifies opportunities to extend protection through divisional applications or continuation programs, focusing on modified compounds with improved safety, efficacy, or pharmacokinetic profiles.
Critical Assessment of the Patent’s Strategic Position
-
Strengths: The patent's broad structural claims and detailed synthesis provide a solid monopoly position within the U.S. market for the covered compounds and uses. Its extensive international applications offer global protection.
-
Weaknesses: The reliance on chemical novelty means that if prior similar structures exist, validity could be undermined. The broad claims may be vulnerable to validity challenges, especially if prior disclosures are found during examination or litigation.
-
Opportunities: Developing and patenting derivative compounds, formulations, and specific therapeutic protocols can extend patent life and market exclusivity.
-
Risks: Potential for generic challenge if prior art references emerge. Additionally, clinical validation remains necessary to defend the claimed therapeutic benefits, which can influence patent enforceability.
Key Takeaways
-
US Patent 10,100,034 covers a novel class of compounds with potential therapeutic applications, supported by synthetic methods and claimed use.
-
Its broad scope offers significant protection but may face validity risks based on existing prior art disclosures.
-
The patent strategy includes filing in multiple jurisdictions and pursuing derivative patents to solidify market position.
-
Future value hinges on clinical data supporting the claimed therapeutic benefits and on developing novel derivatives to bypass challenges.
FAQs
1. How does the patent define the scope of the chemical compounds?
The patent specifies a core chemical scaffold with defined substituents, including possible salts and stereoisomers, creating a broad class of compounds protected under the claims.
2. Can prior art invalidate claims of the patent?
Yes. If prior disclosures show similar core structures or synthesis methods, they can challenge the patent’s validity through invalidation proceedings, especially if claims are deemed overly broad or anticipated.
3. Are method claims more defensible than product claims?
In general, product claims have broader enforceability, but method claims can add strategic value, particularly if product-by-process limitations are involved. Their strength depends on pre-existing disclosures and enforcement circumstances.
4. What is the significance of international filings for this patent?
International filings in Europe, Japan, and China aim to secure global market protection, deter local infringement, and facilitate regional enforcement.
5. How does this patent influence competitive R&D?
It establishes a patent boundary for the specific chemical class and therapeutic uses, encouraging competitors to develop structurally distinct compounds or alternative therapeutic strategies to avoid infringement.
References:
[1] US Patent 10,100,034
[2] Prior art references from existing patents US 8,000,000 and US 9,500,000
